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Heparin-induced endothelial cell cytoskeletal reorganization: A poten-
tial mechanism for vascular relaxation. We have previously shown that
heparin given subcutaneously on a daily basis lowers blood pressure in
hypertensive rat models, and that this blood pressure lowering effect is
endothelium-dependent. The present study describes the effects of hepa-
rin on endothelial cell (EC) apical surface structures and cytoskeletal
elements, namely, aetin and vimentin as well as EC proliferative activity.
The EC line (CRL 1998) was cultured, treated with different concentra-
tions of heparin (0, 50, 100, 500 U/mI) for 4, 24 or 48 hours, and fixed for
scanning electron microscopy (SEM), and immunofluorescence micros-
copy (IFM) studies. Enzyme-linked immunosorhent assays (ELISA) and
flow cytometric analysis were performed on EC monolayers treated with
different concentrations of hcparin for quantitative detection of actin and
vimentin. By SEM study the cell surface showed generalized smoothing as
a result of blunting of surface microvilli with increasing time of exposure
and dosage of heparin. By IFM study, the detectable actin signal within
ECs became progressively reduced in both its cellular distribution and the
apparent number of cells that remained reactive. By 48 hr/500 U heparin,
the actin signal was almost undetectable. Vimentin showed a moderate
reduction in the cellular distribution of labeling. Quantitatively, actin was
significantly reduced after the 24 hour treatment with a higher dose of
heparin (500 U/mI), from a baseline optical density (OD) of 1.12 0.060
to 0.866 0.008 (P < 0.0027). After 48 hours of treatment at both 100
U/mI and 500 U/mI heparin, actin was significantly reduced from a
baseline OD of 1.347 0.063 to 1.090 0.039 (P < 0.0039) and 0.844
0.074 (P < 0.008), respectively. However, vimentin was significantly
reduced only after 48 hours of treatment with a high dose of heparin (500
U/mI), from baseline OD 1.82 0.052 to 1.41 0.004 (P < 0.002). The
flow eytometric findings were virtually identical to the ELISA data for
actin and vimentin. These qualitative and quantitative changes in actin and
vimentin are consistent with apparent smoothing and relaxation of the
EC's apical surface. Labeling with the cell cycle marker MIB-1 (monoelo-
nal antibody Ki-67), showed a progressive reduction in the observed
intensity in heparin treated cells with substantially fewer cells being
positive. After a 48 hour treatment with heparin (500 U/mI), most ECs
displayed only dim labeling of the nucleolus. This finding is consistent with
an antiproliferative effect. Overall, these findings are additive to our
previous observations, and demonstrate that heparin causes EC cytoskel-
etal reorganization which is a potential mechanism for vascular relaxation.
Earlier studies by this group have revealed that heparin func-
tions to lower systemic blood pressure in spontaneously hyperten-
sive (SHR) and Goldblatt hypertensive rats [1—5J. This group has
also demonstrated that addition of exogenous heparin to endo-
thelial cell (EC) primary cultures alters the production of two
major vasoactive substances, endothelin-1 (ET-1) and nitric oxide
(NO). Expression of ET-1 is down-regulated at the protein and
mRNA levels, while production of NO is enhanced. These
observations indicate that heparin affects the expression of two
major vasoactive substances in an opposing fashion which suggests
an important role for heparin in blood pressure regulation [6—8].
Major cellular elements in hypertension are the vascular endo-
thelium and smooth muscle cells. Recent literature increasingly
suggests that ECs may play an important role in blood pressure
regulation and in the biology of systemic hypertension [9, 101. This
function of ECs may be attributable to the release of two
important vasoactive substances, ET-1 and NO. ET-l is a potent
vasoconstrictor [111, whereas NO is a potent vasodilator [12].
These vasoactive substances act locally on vascular smooth muscle
cells (VSMC5) lining the vessels.
Previous studies have reported relationships between the EC's
cytoplasmie microfilaments (cytoskeleton) and blood pressure
levels in a coarctation model of hypertension in the rat [13].
Therefore, further defining the relationship between EC cytoskel-
eton and heparin is fundamental to an understanding of the
pathophysiology of hypertension. The present study was designed
to elucidate the effect of heparin on EC morphological and
cytoskeletal changes. This study focuses on the changes in cy-
toskeletal elements, actin and vimentin, in the context of their
relationship to surface structures and morphology. Cell surface
microvilli contain an actin core structure which runs throughout
and is anchored to the cell membrane [14]. This actin core is in
turn anchored to the intermediate filament web which is made up
of vimentin. Actin constitutes both a structural component and a
contractile element which undergo assembly and disassembly as
needed, whereas vimentin is made up of a relatively constant set
of filaments which are rearranged to accommodate necessary
structural changes in the cell [15].
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Cell culture: Scanning electron microscopy
The endothelial cell line (CRL 1998) was obtained from ATCC
and grown to confluence in 25 cm2 flasks, in Media 199/10% fetal
bovine serum (FBS; Sigma Chemical Co., St. Louis, MO, USA).
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Fig. 1. This scanning electron microscopy (SEM) photograph of untreated cultured endothelial cells (ECs) reveals that untreated ECs are extensively covered
with microvilli and surface ridges. There are numerous large intercellular gaps. SEM X 1280
Cells were harvested by treatment with EDTA solution for two
minutes followed by coliagenase for five minutes and then trypsin
solution for 5 to 10 minutes. Suspended cells were plated for
confluent monolayers (approximately 8,000 cells/well) into Falcon
cell culture well membrane-inserts and grown for 24 hours in
Media 199 with 10% FBS. This approach to culture allows the
cells to assume a polar and, therefore, more natural phenotype
than standard monolayers on glass or plastic. At 24 hours, the
media was replaced by Media 199 supplemented with 0, 50, 100
and 500 U/mi of heparin. These were maintained for 4, 24 and 48
hours at 37°C under 5% CO2. At each time interval, wells from
each treatment group were removed, washed with phosphate
buffered saline (PBS) pH 7.2, fixed in 2% buffered giutaraldehyde,
and processed for scanning electron microscopy (SEM) study
according to a method published previously [161.
Cell culture: Immunofluorescence microscopy
In these studies, ECs were grown to confluence on glass slides
with teflon-masked wells (Cel Line, Inc.) allowing for 10 individ-
ual samples to be tested on each slide. This approach helped to
minimize sample to sample variations. Cells grew well on these
slides and no apparent differences in growth characteristics were
noted between these cells and those grown on membrane-inserts
described before. All studies included both 0 time and 0 treatment/48
hr growth control slides which were used to monitor baseline
expression of all antigens detected. In addition, all slides included a
PBS reagent control well and class-matched primary antibody con-
trol wells to quali' the specificity of labeling observed [17].
In all studies, cells were allowed to adhere and grow on slides
for 24 hours, followed by treatment with Media 199 containing 0,
50, 100 and 500 U/mI of heparin. Slides were maintained under
standard incubation conditions for 4, 24 and 48 hours. At 24
hours, fresh heparin containing media was used for replacement
to maintain the overall relative concentration of heparin for the
treatment period. Slides containing cells were harvested at each
time period by washing with PBS and fixed in methanol for one
hour, washed in PBS and then labeled with monoclonal antibody
to rabbit actin or vimentin (Zymed, South San Francisco, CA,
USA). After washing for one minute in PBS, cells were treated
with fluorescence isothiocyanate conjugated antimouse IgG or
1gM (FITC) secondary antibody (Sigma), and examined by im-
munofluorescence microscopy (IFM).
Enzyme-linked immunosorbent assay
To conduct cell-monolayer enzyme-linked immunosorbent as-
say (ELISA) assays [18], cells were grown to confluence in 96 well
flat-bottomed culture plates (Corning Inc., Corning, NY, USA),
treated with different concentration of heparin or dermatan (0, 50,
100, 500 U/mI) for 4, 24 and 48 hours, washed and fixed in place
with 100% methanol for 24 hours at 4°C. The ELISA was then
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Fig. 2. SEM micrographs of cultured ECs that were treated with 50 U/mI heparinforfour hours (A), 100 U/mI heparin for 24 hours (B), and 500 U/mI heparin
for 48 hours (C). These Figures show progressive decrease in surface microvilli and intercellular gaps with increasing concentration of heparin and
duration of treatment with heparin. In B, the EC surface is almost smooth and the cells are apposed to each other. In C, the EC surface is smooth with
complete blunting of microvilli. Slight or no intercellular gaps are seen in groups of cells (X 2 experiments). A, SEM >< 1280; B, SEM X 1280; C, SEM
x1280
performed directly on these cell monolayers. Following fixation,
plates were washed three times with 0.01 M PBS using a Corning
plate washer, then blocked to prevent nonspecific-binding with
3% FBS in 0.01 M PBS for 30 minutes. The blocking solution was
removed by aspiration. Test antibody mixed with 1% Tween-20
was added to each well (100 pA/well) at concentrations of 10 to 30
jxg/ml. The plates were incubated for one hour at 20°C and then
washed three times with 0.01 M PBS. One hundred microliters per
well of peroxidase conjugated anti-mouse antisera diluted in PBS
at 1:100 was added, and the plates were incubated for one hour at
20°C. Plates were washed three times with PBS. Chromophore-
substrate solution was made by addition of two chromophore
diaminobenzidine (DAB) tablets/lO ml of carbonate buffer. Chro-
mophore-substrate solution was added to each well (100 p1/well),
and plates were incubated at 20°C. Reactions were monitored and
read at 405 nm within 30 minutes using a VMax microtiter plate
reader and software.
Cell culture: Flow cytometty
Twenty-five cm2 flasks were seeded with 2 X i0 ECs (CRL
1998) and cultures were maintained until 100% confluence was
achieved. Cells were then maintained in serum-free media for 24
hours and subsequently exposed to different concentrations of
heparin (0, 50, 100, 500 U/mi). This treatment was maintained for
4, 24, and 48 hours. At each time interval, cells were harvested and
fixed overnight in 1% formalin. Each sample was washed twice in
PBS and divided into two sets: test and control (one pair for actin
and one pair for vimentin). The actin set was initially treated with
mouse monoclonal primary antibody to rabbit actin (IgG,
Zymed). After two PBS washes, actin set was stained with FITC
anti-mouse IgG secondary antibody (Sigma Immunochemicals).
The vimentin set was initially treated with monoclonal mouse
anti-vimentin primary antibody (1gM, Zymed). After two PBS
washes, the vimentin set was stained with FITC anti-mouse 1gM
secondary antibody (Sigma Immunochemicals).
Flow cytometry was performed using a Becton-Dickinson FAC-
Scan [19]. Cells were gated using forward and side scatter profiles
to exclude debris and clumps. Gated cells were analyzed for
fluorescence using an Argon Laser with excitation at 488 nm and
emission evaluated between 530 to 580 nm. At least 10,000 cells
were analyzed for all samples.
Results
SEM studies
Untreated (OU ml/heparin) cultured ECs exhibited a rough
surface, with large intercellular gaps and numerous microvilli
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Fig. 3. Immunofluorescence labeling. A (top left). The detectable actin signal is pronounced in cultured ECs treated with 0 U/mI heparin for 24 hours(x 150). B (second left). After treatment with 500 U/ml heparin for 24 hours, the actin signal was markedly reduced and disassembled in most ECs
(x 150). C (third left). After 48 hours treatment with 500 U/mi heparin in which actin signal was almost undetectable (X 150) (X 4 experiments).
Fig. 4. Immunofluorescence labeling. A (top right). Effect of treatment with 0 U/mI heparin at 0 hours. Extensive vimentin web and filaments were
detected throughout all the cells (X330). B (second right). After treatment with 500 U/mI heparin for 48 hours, the vimentin filaments were retracted
into a perinuclear location and few or no cytoplasmic webs are observed (X330) (X 4 experiments).
OU 50U 100U 500U
Heparin dose
Fig. 6. Percent reduction of cultured ECs positive for actin in a dose-
dependent fashion by heparin treatment for 48 hours. By 48 hours, only
27.5% of ECs were positive for actin labeling which was significantly (*P
< 0.001) lower than 71.5% ECs positive for actin labeling with OU/ml
heparin (X 4 experiments).
(Fig. 1). After treatment with heparin, the cell surface revealed a
progressively increased smoothing as a result of blunted surface
microvilli (Figs. 2 A-C). A progressive decrease was noted in the
number of microvilli and other surface projections (undulations
and ridges) and in the intercellular gaps following increased
dosage and duration of heparin treatment. After heparin treat-
ment for 48 hours, surface microvilli were mostly blunted, display-
ing a distinctly modified presentation of the cell surface. In
addition, the cells were apposed to each other leaving slight or no
discernible intercellular gaps (Fig. 2C).
Immunofluorescence studies
In the case of actin, an overall lowering of the detectable signal
was observed with heparin treatment. This was determined by the
number of reactive cells within a given field, and by the intensity
of reaction in the cells. Changes in the detectable actin signal
observed within these cells upon exposure to heparin correlated
with time/concentration of exposure in the same manner as EC
surface relaxation observed by scanning electron microscopy.
Thus, cellular actin was detected in most cells at 24 hours with
OU/ml heparin treatment and was widely distributed throughout
the cytoplasm of these cells (Fig. 3A). With increasing concentra-
tion of heparin and duration of exposure, the detectable actin
signal within these cells became markedly reduced in both its
distribution and the number of cells that remained reactive as well
as displaying organizational disruption (Fig. 3B). By 48 hours of
500 U heparin exposure, actin was hardly detectable (Fig. 3C).
Unlike actin, a moderate change in detectable vimentin signal
related to the concentration of heparin and duration of its
exposure was also noted. At 0 (OU/ml heparin) time, these cells
showed an extensive cytoplasmic web of vimentin filaments
throughout most of the cell body (Fig. 4A). However, as time and
concentration of heparin treatment progressed, the organization
of vimentin had undergone moderate changes. Thus, the detect-
able cytoplasmic vimentin web was modified and eventually
disappeared, while the perinuclear vimentin "core" structure
became larger and more dense in terms of labeling intensity (Fig.
4B). These observations are also consistent with the cell surface
changes already described.
In addition to studies of ECs morphology and cytoskeletal
rearrangements, labeling studies were also conducted with the cell
cycle marker MIB-1 using the monoclonal antibody Ki-67. This
antibody has been reported to label a protein/DNA complex
which assembles to differing degrees within the nucleus during all
stages of the cell cycle except G0. Loss of this signal is therefore
considered to represent cellular quiescence and slow or no
proliferation [20, 21]. In our studies, Ki-67 labeled most cell nuclei
at 0 (OU/ml heparin) treatment time with an intense pattern
which involved the nucleolus and a generalized speckled pattern
in the nucleoplasm (Fig. 5A). With heparin treatment, the label-
ing pattern showed a progressive reduction in observed intensity
and with substantially fewer cells being positive. After a 48 hour
treatment with 500 U/ml heparin, most ECs displayed only dim
labeling of the nucleolus (Fig. 5B). These results suggest that
heparin has an antiproliferative effect on cultured ECs. Such an
antiproliferative effect has also been noted in VSMCs following
heparin treatment [22] and may reflect a similar or identical
pathway in both cell types.
Fig. 5. Immunofluorescence labeling. A (third right). After treatment with 0 U/mI heparin for 48 hours, the ECs MIB-1 display marked signalling in all
ECs nuclei (X150). B (bottom right). After treatment with 500 U/mI heparin for 48 hours, both the number and intensity of positive nuclei for MIB-1
are markedly reduced (X 150) (X experiments).
Fig. 7. (bottom left) Flow cytometric histogram of cultured ECs (CRL 1998) treated with actin antibody. Red curve displays the background fluorescence
of ECs labeled with isotypic control antibody. Grey curve represents actin labeling of heparin untreated cells at 48 hours. Green, brown and blue curves
represent actin labeling of ECs treated with 50 U/mI, 100 U/mi or 500 U/mI of heparin, respectively. After 48 hours of incubation, shift of the curves
to the left represents a decrease in fluorescence intensity of actin labeling with increasing dose of heparin.
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Table 1. Heparin-induced changes in detectable actin
Duration of
treatment 0 Units/ml 50 Units/mI 100 Units/mI 500 Units/mI
4 hours 1.10 0.116 1.09 0.598 1.21 0.126 1.06 0.051
P 0.9402 0.3268 0.6625
24 hours 1.12 0.060 1.15 0.040 1.15 0.030 0.866 0.008
P 0.4478 0.4554 0.0027a
48 hours 1.347 0.063 1.308 0.102 1.090 0.039 0.844 0.074
P 0.5991 0.0039a 0.0008a
Values are reported as optical density (OD). P values indicate relative significance of difference between 0, 50, 100 and 500 units/mI treatment groups
at each time interval.
a Statistically significant
Table 2. Heparin-induced changes in detectable vimentin
Duration of
treatment 0 Units/mI 50 Units/mI 100 Units/mI 500 Units/mI
4 hours 1.55 0.2549 1.68 0.0390 1.57 0.0360 1.55 0.1062
P 0.4341 0.8895 0.9937
24 hours 1.76 0.0700 1.75 0.0473 1.65 0.0225 1.50 0.1640
P 0.9080 0.0591 0.0697
48 hours 1.82 0.052 1.788 0.0314 1.77 0.0344 1.41 0.004
P 0.2598 0.2318 0.0002
Values are reported as optical density (OD). P values indicate relative significance of difference between 0, 50, 100 and 500 units/ml treatment groups
at each time interval.
a Statistically significant
Table 3. Dermatan sulfate-induced changes in detectable actin
Duration of
treatment 0 Units/mI 50 Units/mI 100 Units/mI 500 Units/mI
4 hours 0.155 0.16 0.105 0.005 0.107 0.003 0.158 0.023
P 0.3928 0.4565 0.1580
24 hours 0.124 0.02 0.147 0.006 0.135 0.01 0.162 0.088
P 0.1815 0.3890 0.5042
48 hours 0.120 0.03 0.112 0.004 0.128 0.026 0.145 0.016
P 0.7535 0.7239 0.2620
Values are reported as optical density (OD). P values indicate the statistical significance of difference between 0 treatment and 50, 100 or 500 units/mI
treatment groups at each time interval.
ELISA
ELISA results demonstrating quantitative changes in actin and
vimentin are presented in Tables 1 and 2. Table 1 illustrates that
four hours heparin treatment did not reduce actin. After 24 hours,
a significant reduction in actin was noted at a higher dose of
heparin (500 U/ml). At 48 hours, a significant decrease in actin
was observed with both 100 and 500 U/ml of heparin. Vimentin
showed no change with heparin treatment for 4 and 24 hours.
However, a significant decrease in vimentin was observed follow-
ing 48 hours of treatment with a high dose (500 U/mi) of hepariri
(Table 2). No significant change in actin signal was observed in
cells treated with different concentrations of dermatan at each
time interval (Table 3).
Flow cytomet.'y
After four hours and 24 hours of heparin treatment, actin
labeling of ECs did not significantly change. After 48 hours of
heparin treatment, actin labeling in ECs was reduced significantly
and in a dose-dependent fashion (Fig. 6). The rate of reduction of
ECs actin labeling was highly significant (P < 0.001). A progres-
sive decrease in fluorescence intensity of actin labeling in ECs was
noted with increasing dose of heparin (Fig. 7). After 48 hours of
treatment with high dose of heparin (500 U/mm), a significant
decrease in fluorescence intensity of vimentin labeling in ECs was
also noted.
Discussion
Observations made in this study demonstrate time and dose-
dependent effects of heparin on the surface configuration, as well
as cytoskeletal elements, actin and vimentin in cultured ECs. The
overall surface effects of heparin on ECs are blunting of surface
structures, particularly microvilli and surface ridges, and loss of
intercellular gaps. These effects result in smoothing and apparent
relaxation of the apical cell surface. The most likely interpretation
of these data are that heparin functions to cause cytoskeletal
reorganization and/or inhibit protein expression within the
treated endothelial cells. In particular, the blunting of surface
microvilli strongly suggests that actin, which makes up the struc-
tural core protein of microvilli, is being disassembled [14]. Cellu-
lar microvilli is a site of Ca2 absorption [14], and since heparin
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has been shown to suppress Ca2 entry into the cell [5], blunting
of microvilli may be due to loss of calcium-dependent actin
filaments. The decrease of actin signal by heparin may represent
a reduction of active microfilaments rather than of microvilli,
because microfilaments occupy a large portion of the cell struc-
ture. Disturbance of microfilaments may cause expansion of
intercellular gaps and increase in cell permeability [23]. Thus, by
significantly reducing actin signal as shown by ELISA and flow
cytometry, heparin will exert a reverse effect on intercellular gaps
(Fig. 2C) and decrease in cell permeability. Vimentin which is the
intermediate filament protein and the internal anchor for mi-
crovilli also showed a significant change but at a much slower rate
than actin by both ELISA and flow cytometry techniques.
Endothelial cells contain bundles of cytoplasmic filaments [15,
24, 25]. Generally, the cellular cytoskeleton contains actin (thin
filament), intermediate filaments and microtubules. ECs contain a
large amount of actin and intermediate filaments [25]. The
cellular microvilli contain an actin-based cytoskeleton; however,
thus far, the function of this cytoskeleton is not clearly and
completely defined [14]. Intermediate filaments comprising
mostly vimentin are not contractile; instead they function as a part
of the cytoskeleton to maintain cell shape and resist mechanical
stress [24, 26]. In the endothelium, the intermediate filaments may
provide an elastic supporting structure which allows configura-
tional changes, thereby resisting intravascular pressure changes
[27].
While the role of intermediate filaments such as vimentin in the
pathophysiology of hypertension is unknown, a relationship be-
tween actin and blood pressure changes has been documented
[13]. To investigate this relationship, Gabbiani, Badonnel and
Rona [13] developed a coarctation model of hypertension in the
rat and elegantly showed that ECs in the hypertensive segment of
aorta (blood pressure 160 mm Hg) contained extensive numbers
of microfilaments compared to those in the normotensive segment
of the aorta (blood pressure 25 mm Hg). The few microfilaments
seen in the normotensive segment of the aorta were similar to
those in the normotensive controls. Fixation of actin autoantibod-
ies to the EC filaments of the hypertensive segment indicates, that
at least some of these filaments were actin, and probably part of
a contractile apparatus. Therefore, these authors suggested that
increased blood pressure may play a role in the formation of actin
filaments.
Although the precise role of cytoplasmic actin filaments in
hypertension has not been elucidated, our observations may shed
some light on this anatomic-pathologic relationship. We have
reported that in hypertensive rat models, heparin consistently
lowers blood pressure. This blood pressure lowering effect of
heparin may be at least, partly due to decreased ET-1 and
increased NO production by ECs [28]. However, the mechanism
as to how changes in these vasoactive substances cause vascular
relaxation and decreased vascular resistance has remained un-
clear. In this study, we have shown that in cultured ECs, heparin
exerts a potent inhibitory effect on EC actin, while simultaneously
changing cellular organization of vimentin. Since a previous study
has shown an association between enhanced detection of EC actin
and elevated blood pressure [13], a reduction of EC actin by
heparin as shown in this study should reflect upon vascular
relaxation, that is, blood pressure reduction. Heparin's effect on
EC's cytoskeletal elements suggest that similar changes may also
occur in VSMCs. Since heparin has already been shown to have a
profound antiproliferative effect on VSMCs [3, 22, 28], it is likely
that heparin will induce similar cytoskeletal changes in VSMCs, as
in ECs. Reduction in VSMC contractile actin would, in turn, be
reflected in further reduced vascular tone and blood pressure.
Acknowledgments
This study was supported in part by Medical Research Service of the
Department of Veterans Affairs and by a Biomedical Research Support
Grant from Wright State University, School of Medicine, Dayton, Ohio.
This paper was presented at the 36th Annual National Student Research
Forum held at the University of Texas Medical Branch at Galveston,
Texas, on April 6 to 8, 1995 and was awarded the Internal Medicine
Research Award. This paper was also presented in a poster workshop at
the National Meeting of the American Federation for Clinical Research,
May 5 to 8, 1995, San Diego, CA. The authors gratefully acknowledge the
contribution made by Dr. Hasib A. Ibne-Rasa in the study of heparin-
induced endothelial cell responses. Dr. Mehrotra is currently located at
the Long Island Jewish Medical Center, New York; Dr. Mehling is a
fourth year medical student and AOA Scholar.
Reprint requests to Anil K Mandal, M.D., Department of Medicine, Wright
State University at the VA Medical Center, 4100 West Third Street, Dayton,
Ohio 45428, USA, or Timothy W. Lyden, Ph.D., Department of Microbiology
and Immunology, Wright State University, 3640 Colonel Glenn H., Dayton,
Ohio 45435, USA.
References
1. MANDAL AK,OLEINICK SR, JAMES TM, WIsE W, LONG H, NORDOUIST
JA, BELL RD, YUNICE AA, PARKER D: Glomerular thrombosis in
spontaneously hypertensive rat. II. Immunofluorescence microscopy.
III. Effect of heparin. Microvasc Res 16:373—390, 1978
2. Susic D, MANDAL AK, KENTERA D: Heparin lowers the blood
pressure in hypertensive rats. Hypertension 4:681—685, 1982
3. Susic D, MANUAL AK, RADUJKOVIC G, VuLovlc D, KENTERA D:
Prostaglandin synthesis inhibitors potentiate the antihypertensive
effect of heparin in spontaneously hypertensive rats. J Lab Clin Med
111:63—72, 1988
4. Susic D, MANUAL AK, KENTERA D: Hemodynamic effects of chronic
alteration in hematocrit in spontaneously hypertensive rats. Hyperten.
sion 6:262—266, 1984
5. Yoszoicw K, MANUAL AK, KOHNO M, HoRlo T, MURAKAWA K,
YASIJNARI K, TAKEDA T: Heparin suppresses endothelin-1 action and
production in spontaneously hypertensive rats. Am J Physiol 263:
R1035—R1041, 1992
6. YOKOKAWA K, KOHNO M, MANUAL AK, TAHARA K, YANAGISAWA M,
TAKEDA T: Heparin suppresses endothelin-1 peptide and mRNA
expression in cultured endothelial cells of spontaneously hypertensive
rats. JAm Soc Nephrol 4:1683—1689, 1994
7. YOKOKAWA K, TAHARA H, KOHNO M, MANDAL AK, YANAGISAwA M,
TAKEDA T: Heparin regulates endothelin production through endo-
thelium-derived nitric oxide in human endothelial cells. J Clin Invest
92:2080—2085, 1993
8. Kol-INo M, YOKOKAWA K, HoRlo T, IKEDA M, KURIHARA N, MANUAL
AK, TAKEDA T: Heparin inhibits endothelin-1 production in cultured
rat mesangial cells. Kidney mt 45:137—142, 1994
9. FOLKOW B: Early structural changes in hypertension: pathophysiology
and clinical consequences. J Cardiovasc Pharmacol 22:S1—S6, 1993
10. LUSCHER TF, BOULANGER C, YANG Z, D0HI Y: Interaction between
endothelin and endothelium-derived relaxing factor(s), in Endothelin,
edited by RUBANYI GM, Oxford University Press, New York, 1992, pp
125—136
11. YANAGISAWA M, KURIHARA H, KIMURA 5, TOMOBE Y, KOBAYASHI Y,
MITusul Y, YAZAKI Y, GoTo K, MASAKI T: A novel potent vasocon-
strictor peptide produced by vascular endothelial cells. Nature (Lond)
332:411—415, 1988
12. VALLANCE P, COLLIER J, MONCADA 5: Effects of endothelium-derived
nitric oxide on peripheral arteriolar tone in man. Lancet ii:997—1000,
1989
13. GABBJANI G, BADONNEL MC, RONA G: Cytoplasmic contractile appa-
ratus in aortic endothelial cells of hypertensive rats. Lab Invest
32:227—234, 1975
1516 Mandal et al: Heparin-induced vascular relaxation
14. BRETSCHER A: Microfilament structure and function in the cortical
cytoskeleton. Ann Rev Cell Biol 7:337—374, 1991
15. TAKCHANA K, ABE M, YAMAGUCHI M, UCHIDA T, INAGAKI M,
YAMAMOTO K, MASTY J, WINNARD A, UEDA H, MIYATA H: Cytoplas-
mic filaments in the endothelial cells of the sheathed capillary: An
ultrastructural and immunocytochemical study in the pig spleen. Acta
Anatomica 143:294—300, 1992
16. MANDAL AK, TAYLOR CA, BELL RD, HILLMAN NM, JARNOT MD,
CUNNINGHAM JD, PHILLIPS LG: Eiythrocyte deformation in ischemic
acute tubular necrosis and amelioration by splenectomy in the dog.
Lab Invest 65:566—576, 1991
17. LYDEN TW, No AK, ROTE NS: Modulation of phosphatidylserine
epitope expression on BeWo cells during forskolin treatment. Placenta
14:1—10, 1993
18. TATAROWICZ WA, LURAIN NS, THOMPSON KD: In situ ELISA for the
evaluation of antiviral compounds effective against human cytomega-
lovirus. J Viro Meth 35:207—215, 1991
19. BAUS E, URBAIN J, LEO 0, ANDRIS F: Flow cytometric measurement
of calcium influx in murine T cell hybrids using Fluo-3, and an
organic-anion transport inhibitor. J Immunol Meth 173:41—47, 1994
20. VAN DIERENDONCK JH, KEIJZER R, VAN DE VELDE CJH, CORNELISSE
CJ: Nuclear distribution of the Ki-67 antigen during the cell cycle:
Comparison with growth fraction in human breast cancer cells. Cancer
Res 49:2999—3006, 1989
21. LOPEZ F, BELLOC F, LACOMBE F, DUMAIN P, REIFFERS J, BERNARD P,
BOISSEAU:. The labeling of proliferating cells by Ki-67 and MIB-1
antibodies depends on the binding of a nuclear protein to the DNA.
Exp Cell Res 210:145—153, 1994
22. CASTELLOT JJ, WRIGHT TC, KARNOVSKY MJ: Regulation of vascular
smooth muscle cell growth by heparin and heparan sulfates. Sems
Thromb Hemos 13:489—503, 1987
23. SHASBY DM: Role of endothelial cell cytoskeleton in control of
endothelial permeability. Circ Res 51:657—661, 1982
24. SEKIA, ABE M: Scanning electron microscopic studies on the micro-
vascular system of the spleen in the rat, cat, dog, pig, horse and cow.
Jpn J Vet Sci 47:237—249, 1985
25. HATAET: Electron microscopic studies on the ellipsoid of the cat
spleen with special reference to the filaments in the endothelial cell.
Arch Histol Cytol 41:177—186, 1978
26. ERIKs50N A, THORNELL LE: Intermediate (skeleton) filaments in the
heart Purkinje fibers. A correlative morphological and biochemical
identification with evidence of a cytoskeletal function. J Cell Biol
80:231—247, 1979
27. BLUE J, WEISS L: Electron microscopy of the red pulp of the dog
spleen including vascular arrangements, periarterial macrophage
sheaths (ellipsoids) and the contractile innervated reticular meshwork.
Am JAnat 161:189—218, 1981
28. MANDAL AK, LYDEN TW, SAKLAYEN MG: Heparin lowers blood
pressure: Biological and clinical perspectives. Kidney ml 47:1017—
1022, 1995
